Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Trade Secrets: Coherus Hiring Of Amgen Exec Leads To Theft Suit

Mar 07 2017

• By Brenda Sandburg

Clouds-Lightning-Storm_1200x675

Related Content

Sandoz Sanguine On Market Opportunity Despite Biosimilar Neulasta Setback

Jan 27 2017

Coherus, In Ring As A Biosimilar Contender, Hopes To Smack Down Humira

Oct 19 2016

Ex-Pfizer Employee Overseeing Xeljanz Global Marketing Sued For Trade Secret Theft

Mar 02 2017

Biosimilars: Sandoz Pegfilgrastim Review, Amgen Adalimumab Launch Extended To 2018

Oct 29 2016

Related Companies

Coherus Oncology, Inc.

Amgen, Inc.

Genentech, Inc.

Pfizer Inc.

Medivation, Inc.

Novartis AG

Novartis AG

Viatris Inc.

Biocon, Ltd.

AbbVie Inc.

Additional Topics

United States Biosimilars Legal Issues Intellectual Property Policy BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window